Yes, I’m on Twitter- alandove: Mine get rejected for lack of adequate controls. RT @noahWG My thought experiments rarely yield anything publishable.
- alandove: Whoever's behind the @FakeElsevier tweets is friggin' brilliant. And no, it's not me.
- alandove: A case of scientific censorship that doesn't involve #H5N1: http://t.co/MRx664EW Mining industry vs. NCI and NIOSH.
- alandove: @_colm_ @profvrr @newprof1 Indeed. What good could come of studying deadly microbes, after all?
- alandove: RT @chrislhayes: So, GOP votes against Violence Against Women act, for transvaginal ultrasounds and has an all male hearing on birth con ...
- alandove: Science is sexy, but not like that. @Ananyo Hum. istock thinks this is what a young female scientist looks like http://t.co/mM9KnKX6
- alandove: Blog post: Exploring the Sourdoughome. http://t.co/70vxEEar
- alandove: @easternblot Zhang @ Michigan or some such? Maybe they recently changed their address scheme and a student was just first in line at time.
- alandove: RT @Etche_homo: MT @Etche_homo Heartland buys anti-climate change "scientists" for $300K: p13 of http://t.co/im95AkoM #deniergate
- alandove: I have a "Drafts" folder? How much effort am I supposed to put into these 140-character messages?
Tag Archives: science publishing
Open Access vs. Local Politics
Someone just asked me what I thought of Michael Eisen’s op-ed piece that came out in the New York Times a couple of weeks ago. Eisen wrote about a new bill in Congress that would roll back a NIH policy … Continue reading
Who’s More Productive? No, How.
There’s a common belief that science shouldn’t try to answer “why” questions. Instead, it should focus on what it’s good at: answering “how” questions. I wondered whether that was really true, so I compared the relative productivity of Who, What, … Continue reading
Middlemen, Marketing, and a Modest Proposal
During the heady days of the dot-com bubble, “disintermediation” was one of the hot buzzwords. E-commerce proponents proclaimed the death of stores, the shortening of supply chains, and the impending arrival of a new world in which producers sold their … Continue reading
Readbacks and Researchers
Recently, there’s been a major debate in the online science journalism community about a common but little-discussed practice in the news business: readbacks. That’s what we call the article excerpts journalists sometimes send to sources ahead of publication, during the … Continue reading
Accentuate the Negative
When a clinical trial fails, everybody loses: the patients who participated hoping to benefit, the patients who didn’t participate but hoped to get the promising new drug once it hit the market, the researchers who dedicated thousands of hours of … Continue reading
Elsevier Makes Good: Original Wakefield Takedown Now Free
Awhile back, I blogged about a particularly insidious glitch in the biomedical literature, in which a fraudulent study that caused enormous harm was available for free, while a contemporary – and strikingly prescient – commentary that eviscerated that study was … Continue reading
Posted in Uncategorized
Tagged autism, Elsevier, fraud, open access, science publishing, vaccines
Comments Off
How about Walking the Walk?
From the inbox: Below is information about articles being published in the April 19 issue of Annals of Internal Medicine. The information is not intended to substitute for the full articles as sources of information. Annals of Internal Medicine attribution … Continue reading
The Press Release Revision Cycle
First, let’s read the paper, see how much we can understand, and quote the authors from their peer-reviewed text. That will ensure we have the facts right, but it will give us a caveat-filled press release with this rather uninspiring … Continue reading
This is A Link to Something I Wish I Had Written
This is a sentence trying to claim credit for discovering this article, which in fact most interested people would have found on their own. This is a sentence fragment setting up the link, which is here. This sentence tries to … Continue reading
Probing the Proteome
My most recent piece for Science/AAAS is now online. I talked to several researchers who are using very cool techniques to find new biomarkers for diseases, and it was a fun piece to write. It appeared in the “AAAS Business … Continue reading
Posted in Uncategorized
Tagged biomarkers, proteomics, published work, science publishing
Comments Off